Aldactone and Votrient drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Aldactone and Votrient. Common interactions include pyrexia among females and asthenia among males.
The phase IV clinical study analyzes what interactions people who take Aldactone and Votrient have. It is created by eHealthMe based on reports of 18 people who take Aldactone and Votrient from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
18 people who take Aldactone and Votrient together, and have interactions are studied.
What is Aldactone?
Aldactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 43,456 Aldactone users for its effectiveness, alternative drugs and more.
What is Votrient?
Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 24,021 Votrient users for its effectiveness, alternative drugs and more.
Number of Aldactone and Votrient reports submitted per year:
Common Aldactone and Votrient drug interactions by gender *:
- Acute sinusitis
- Productive cough
Common Aldactone and Votrient drug interactions by age *:
- Cerebral haemorrhage
- Haemorrhage intracranial
- Upper respiratory tract infection
- Left ventricular dysfunction
- Cardiac failure
- Atrial fibrillation
- Decreased appetite
- Abdominal distension
Common conditions people have *:
- High Blood Pressure: 8 people, 44.44%
- Renal Cell Carcinoma (a kidney cancer): 8 people, 44.44%
- Pneumonia: 4 people, 22.22%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 22.22%
- Overdose: 4 people, 22.22%
- Cough: 4 people, 22.22%
- Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 4 people, 22.22%
- Metastases To Lung (cancer spreads to lung): 4 people, 22.22%
- Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 2 people, 11.11%
- Synovial Sarcoma (tumour of synovial membrane of joint): 2 people, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Aldactone and Votrient?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Costa DA, de Almeida SB, Barata PC, Quintela A, Cabral P, Afonso A, Silva JM, "Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach", Case Reports in Oncology, 2013 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Aldactone and Votrient:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Aldactone side effects:
- Breathing difficulty: 3,116 reports
- Hyperkalemia (damage to or disease of the kidney): 2,693 reports
- Hypotension (abnormally low blood pressure): 2,582 reports
- Diarrhea: 2,411 reports
- Fatigue (feeling of tiredness): 2,247 reports
- Weakness: 2,219 reports
Browse all side effects of Aldactone:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Votrient side effects:
- Death: 4,200 reports
- Diarrhea: 3,921 reports
- Fatigue (feeling of tiredness): 2,695 reports
- High blood pressure: 2,143 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 1,564 reports
- Nausea and vomiting: 1,494 reports
- Drug ineffective: 1,218 reports
Browse all side effects of Votrient:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Aldactone interactions:
- Aldactone and Lasix: 15,781 reports
- Aldactone and Furosemide: 5,715 reports
- Aldactone and Aspirin: 5,389 reports
- Aldactone and Digoxin: 3,322 reports
- Aldactone and Lipitor: 2,760 reports
- Aldactone and Coumadin: 2,755 reports
- Aldactone and Allopurinol: 2,427 reports
- Aldactone and Metformin: 2,387 reports
- Aldactone and Plavix: 2,346 reports
- Aldactone and Omeprazole: 2,315 reports
Browse all interactions between Aldactone and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Votrient interactions:
- Votrient and Amlodipine: 904 reports
- Votrient and Aspirin: 703 reports
- Votrient and Lisinopril: 632 reports
- Votrient and Metformin: 434 reports
- Votrient and Ondansetron: 399 reports
- Votrient and Simvastatin: 397 reports
- Votrient and Omeprazole: 392 reports
- Votrient and Vitamin d: 385 reports
- Votrient and Oxycodone: 380 reports
- Votrient and Losartan: 379 reports
Browse all interactions between Votrient and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on spironolactone and pazopanib hydrochloride (the active ingredients of Aldactone and Votrient, respectively), and Aldactone and Votrient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Aldactone and Votrient.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dulera and Disease Recurrence - a second ago
- Phenytoin vs. Mysoline - 2 seconds ago
- Gemcitabine and Anal Fistula - 4 seconds ago
- Rizatriptan Benzoate vs. Toprol-Xl - 5 seconds ago
- Duexis and Liver Disorder - 5 seconds ago
- Vanadyl Sulfate and Breathing Difficulty - 10 seconds ago
- Paroxetine Hydrochloride vs. Serzone - 16 seconds ago
- 5 Htp vs. Desvenlafaxine - 23 seconds ago
- Temaz and Synjardy drug interaction - 23 seconds ago
- Mirtazapine and Suicidal Behavior - 29 seconds ago